Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Elekta Ab (EKTAF)

Elekta Ab (EKTAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elekta Ab

Description:

Elekta AB is a Sweden-based biotechnology company that provides information systems for treating cancer and brain conditions. Its systems diagnose and treat brain disorders and use radiation on cancer patients. The Company produces digitally controlled linear accelerators for radiation therapy. It also offers Precise, a system that using multiple photon energies. It also produces Leksell Gamma Knife Perfexion, a stereotactic radiosurgery which facilitates the conduction of procedures on the brain, cervical spine, head, and neck. Other products include Synergy, a high resolution three-dimensional volumetric imaging suite; Leksell Sterotactic System, a three-dimensional reference system that helps surgeons treat brain disorders; Elekta Axesse, a six-dimensional robot image guided radiosurgery stem for spinal treatments; and Elekta Neuromag, a magnetoencefalography system that gains data from the brain. The Company offers training and service for all of its devices and software applications. The Company sells its devices to hospitals, physicians, and research organizations.

Key Statistics

Overview:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K
Short Volume Ratio 1.00

Growth:

1-Year Return -0.92%
3-Year Return -38.29%
5-Year Return -14.29%

Per-Share Information:

Latest Earnings Date N/A
Next Ex-Dividends Date 08/29/14
Dividend Payable Date 09/05/14
Dividend Payout Ratio 0.00%

EKTAF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 26.49
Price/Book 5.65
Book Value/Share N/A
Interest Coverage N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar